KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Interest Coverage Ratio: 2018-2025

Historic Interest Coverage Ratio for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to -283.50.

  • Castle Biosciences' Interest Coverage Ratio fell 1221.94% to -283.50 in Q3 2025 from the same period last year, while for Sep 2025 it was -226.84, marking a year-over-year decrease of 10542.58%. This contributed to the annual value of 15.03 for FY2024, which is 100.24% up from last year.
  • Per Castle Biosciences' latest filing, its Interest Coverage Ratio stood at -283.50 for Q3 2025, which was down 40.05% from -202.43 recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Interest Coverage Ratio peaked at 44.02 during Q4 2024, and registered a low of -15,171.00 during Q4 2021.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -390.79 (2024), whereas its average is -2,273.96.
  • Per our database at Business Quant, Castle Biosciences' Interest Coverage Ratio tumbled by 197,543.30% in 2021 and then spiked by 101.56% in 2024.
  • Quarterly analysis of 5 years shows Castle Biosciences' Interest Coverage Ratio stood at -15,171.00 in 2021, then surged by 62.38% to -5,708.00 in 2022, then skyrocketed by 50.44% to -2,829.00 in 2023, then soared by 101.56% to 44.02 in 2024, then slumped by 1,221.94% to -283.50 in 2025.
  • Its Interest Coverage Ratio was -283.50 in Q3 2025, compared to -202.43 in Q2 2025 and -1,642.82 in Q1 2025.